Increased risk of SSEs in bone-only metastatic breast cancer patients treated with zoledronic acid

BACKGROUND: Bone represents one of the most common sites to which breast cancer cells metastasize. Patients experience skeletal related adverse events (pathological fractures, spinal cord compressions, and irradiation for deteriorated pain on bone) even during treatment with zoledronic acid (ZA). Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanae, Masashi, Fujimoto, Shinichiro, Tane, Kaori, Tanioka, Maki, Fujiwara, Kimiko, Tsubaki, Masanobu, Yamazoe, Yuzuru, Morishima, Yoshiyuki, Chiba, Yasutaka, Takao, Shintaro, Komoike, Yoshifumi, Tsurutani, Junji, Nakagawa, Kazuhiko, Nishida, Shozo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581372/
https://www.ncbi.nlm.nih.gov/pubmed/28884071
http://dx.doi.org/10.1016/j.jbo.2017.08.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5581372/
https://www.ncbi.nlm.nih.gov/pubmed/28884071
http://dx.doi.org/10.1016/j.jbo.2017.08.004

Ejemplares similares